Amgen stock gains as MariTide concerns addressed AMGN:NASDAQ

November 14, 2024

Shares of Amgen Inc. (NASDAQ:AMGN) saw a boost in trading after the company addressed concerns regarding its MariTide drug. MariTide, which is used to treat certain types of cancer, had come under scrutiny due to potential bone safety issues linked to obesity. However, Amgen quickly denied these concerns, stating that they have conducted extensive studies and found no evidence of increased risk. This reassurance has led to a positive response from investors, resulting in a gain in the company's stock value. For individuals interested in investing in Amgen, it is recommended to seek the guidance of professionals from Stocks Prognosis to get a better understanding of the future movement of the company's stock.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

I'm really glad to hear that Amgen has addressed the concerns about MariTide. I believe this drug has great potential in treating cancer, and I'm interested in investing in Amgen's stock

— from ProfitPam at 11-17-2024 15:10

Amgen's denial seems too convenient. It's always worrisome when a company denies any risks associated with its products. I'll wait for more evidence before trusting their statement

— from CashCaleb at 11-17-2024 14:30

Investing in Amgen seems like a safe bet considering the swift response and reassurance they provided. I have faith in the company's ability to overcome any challenges

— from NicholasEdwards at 11-17-2024 13:39

Great news for Amgen! The quick response and reassurance from the company shows their commitment to addressing concerns and maintaining the trust of investors

— from CharlotteCampbell at 11-17-2024 12:48

This news is reassuring and shows that Amgen is dedicated to ensuring the safety and effectiveness of their drugs. I'm considering investing in their stock

— from MeganThompson at 11-16-2024 13:54

The fact that Amgen conducted extensive studies and found no evidence of increased risk is definitely a positive sign. It shows they prioritize patient safety

— from SmartSophie at 11-15-2024 10:33

I'm happy to see that Amgen is proactive in addressing the concerns about MariTide. This will definitely help maintain investor confidence in the company

— from OliverHayes at 11-14-2024 16:28

I've been following Amgen for a while now, and this news is definitely encouraging. I think their stock value will continue to rise

— from MaryJohnson at 11-14-2024 15:54

I'm not convinced by Amgen's quick denial of the concerns. It feels like they're just trying to protect their stock value. I'll wait for more credible information before considering investing

— from FinanceDave at 11-14-2024 06:54

Is Amgen's denial of the bone safety concerns backed by independent research? It's important to know the credibility of their studies before making any investment decisions

— from IsaacPerry at 11-14-2024 00:36

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

November 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

December 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....

January 11, 2025Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership ~1 min.

Amgen Inc. (NASDAQ:AMGN) continues to attract the attention of institutional investors, with a significant 78% ownership held by these financial giants....

February 3, 2025Amgen Inc. Continues to Impress with Strong Quarterly Earnings ~1 min.

Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, once again surpassed expectations with its impressive quarterly earnings report....

December 28, 2024Amgen Inc.'s Stock Shows Promising Gains: Here's the Latest Update ~2 min.

Investors are eagerly searching for information on Amgen Inc. (NASDAQ:AMGN) as the company's stock gains momentum in the market....

Search on StockPrognosis.com

Sections of the site

Amgen stock gains as MariTide concerns addressed AMGN:NASDAQ

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025